CLINICAL GUIDELINE

Gynecological Cytology Screening Recommendations

 

 

PURPOSE:     The following consensus guidelines for screening for cervical cancer and management of HPV positive specimens were developed by faculty at the New York Presbyterian/Columbia University and Weill Cornell Medical Centers and adopted by the Ambulatory Care Network Clinical Quality Improvement Committee for use in the ACN.  Quality Assurance audits will be structured to reflect adherence to these guidelines.

POLICY STATEMENT:   This guideline does not represent a professional care standard governing a provider’s obligations to patients. Care is revised to meet individual patient needs

 

 

AGE TO START PAP SCREENING:  Screening should begin 3 years after the onset of sexual activity, but not later than age 21.

AGE TO STOP PAP SCREENING:  If a woman has had three negative Pap tests and no abnormal cytology in the previous 10 years, screening may be discontinued at age 70.

 

 

SCREENING METHODS:

 

Women up to age 30 years

A Pap test should be obtained every two years, unless a woman is HIV-infected or immunosuppressed for any reason (see below).  Note that even if Pap screening is not indicated at a particular interval following the onset of testing, other testing may be required, including screening for Chlamydia or other Sexually Transmitted Diseases.

The NewYork-Presbyterian Hospital uses liquid based cytology for all patients.

If the Pap test result is atypical squamous cells of undetermined significance (ASC-US), the patient may be managed either:

A)         Using "reflex HPV testing" with referral to colposcopy only if they are HPV    positive (i.e. “high-risk” HPV).

-OR-

B)        Perform two repeat cytology tests at 4-6 month intervals with referral to colposcopy if any of the repeat tests is abnormal.

 


Gynecological Cytology Screening Recommendations (cont.)

 

Women older than 30 years of age

A)         Combining HPV DNA testing with a Pap test identifies more women with high-grade cervical cancer precursors than does cytology alone.  Therefore in women older than 30 years of age both a liquid-based Pap test and a HPV DNA test should be obtained every three years.

Women who are HPV DNA positive but who have a normal Pap should have both tests repeated in 6 to 12 months.  A referral to colposcopy should occur if the repeat Pap is LSIL or greater or if they remain HPV positive.

-OR-

B)        A liquid-based Pap test without HPV testing obtained every two years is also an acceptable screening approach in women over the age of 30 years who are not HIV-infected or immunosuppressed for any reason. 

 

HIV infected and immunosuppressed patients

A liquid-based Pap test (without HPV testing) should be obtained every year regardless of age.

 

Women who have had a complete hysterectomy (cervix removed)

If the complete hysterectomy was performed for benign disease and there
is no prior history of high grade CIN documented in the prior ten years and the patient was adequately screened, further pap screening is not indicated.    In a high risk population, pap screening may be done at the discretion of the provider.

 

 

DOCUMENT MANAGEMENT:  ACN

 

KEY WORDS:              Ambulatory, Practice Site

 

REFERENCES: American College of Obstetics and Gynecology Cervical Cancer Screening Guidelines; Screening for Cervical Cancer

U.S. Preventive Services Task Force (USPSTF)

 

 

 

Approved:  Daniel Hyman, MD, MMM

Chief Medical Officer, Ambulatory Care